Search for Clinical Trial Results
Pseudomonas Infections - 25 Studies Found
Status | Study |
Completed |
Study Name: Pharmacokinetic Evaluation of an 8 -Week Treatment With Inhaled Tobramycin Condition: Pseudomonas Infections Date: 2008-03-04 Interventions:
|
Completed |
Study Name: Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa Condition:
Interventions: |
Completed |
Study Name: Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections Condition: Pseudomonas Aeruginosa Infection Date: 2011-03-14 Interventions:
|
Completed |
Study Name: Efficacy & Tolerability of Tobramycin Podhaler in Bronchiectasis Patients With Chronic Pseudomonas Aeruginosa Infection Condition: Bronchiectasis With Chronic Infection With Pseudomonas Aeruginosa Date: 2014-03-06 Interventions: Drug: Tobramycin |
Completed |
Study Name: Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways Condition:
Date: 2011-07-26 Interventions: Drug: AZLI AZLI 75 mg was administered 3 times daily via the investigational nebulizer. |
Completed |
Study Name: Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization Condition:
Date: 2009-12-17 Interventions: Drug: Colistin Sino-Nasal inhalation, approximately 1 ml / day in each nostril |
Completed |
Study Name: Cipro Inhaler for Cystic Fibrosis Children Ages 6-12 Condition: Pseudomonas Infection Date: 2009-05-28 Interventions: Drug: Ciprofloxacin (Cipro, BAYQ3939) 25 mg inhaled Ciprofloxacin |
Completed |
Study Name: Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers Condition: Healthy Date: 2008-10-22 Interventions:
|
Terminated |
Study Name: Evaluation of Lung Clearance Index in Cystic Fibrosis (CF) Patients, Infected With P.Aeruginosa Condition: Chronic Lung Infection With Pseudomonas Aeruginosa in Cystic Fibrosis Date: 2014-09-22 Interventions: Drug: TIS or TIP 300mg nebulized Tobramycin (Tobramycin inhalation solution(TIS)) or TOBI Podhaler (Tobr |
Approved for marketing |
Study Name: Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection Condition:
Date: 2007-07-09 Interventions: Drug: Aztreonam Lysine for Inhalation 75 mg three times a day via inhalation for 28 days followed by 28 |